ʻO Pancragen kahi peptide synthetic bioactive i haku ʻia me ʻehā amino acids.
ʻO ka noiʻi ʻana i ka hana pancreatic i alakaʻi i nā ʻepekema e ʻike i kahi hormone-e like me ka mea hana i loko o ka pancreatic extracts; ʻO ka hoʻoulu ʻana i ka pancreas ponoʻī ka hopena i ʻike mua ʻia.
ʻAʻole maopopo ka hoʻonohonoho pololei o kēia hormone.
Nā holomua ma molecular biology a ma hope iho ua ʻae ʻia ka ʻenehana synthesis peptide no kāna hana hou ʻana – ka hoʻomau mau ʻana a me ka hoʻololi ʻia ʻana o kahi ʻāpana koʻikoʻi mai ka unuhi kumu ʻo ia ke ala i hana ʻia ai ʻo Pancragen..
Ma hope o ka hoʻohuihui, koʻikoʻi ka waiwai noiʻi lapaʻau i hoʻoili ʻia iā ia.
Hoʻonui i ka paʻa o ka ʻiʻo pancreatic, paipai ana i ka hooponopono ana, a ʻo ka hoʻoponopono ʻana i ka homeostasis metabolic kona mau pono mua i kākau ʻia.
Laulā anti-inflammatory a ʻike pū ʻia nā hopena pale i loko o ke ake, nā puʻupaʻa, nenoaiu a me na mea e ae.
Kaʻina
H2N-Lys-Glu-Asp-Trp-OH
Helu CAS
/
ʻĀpana Molekala
C26H36N6O9
Kaumaha Molekala
576.607
Ka noiʻi ʻana o Pancragen Peptide
1.Palekana a me ka hana hou ʻana o Nā ʻāpana β-pancreatic
ʻO ka pau ʻana o kēia mau cell ke kumu nui o ka pathological diabetes.
Hoʻohālike i nā kumu ulu endogenous a i ʻole nā hōʻailona ola, ʻO ka pale ʻana i ka apoptosis kahi hana nui; pale ana (ma ka liʻiliʻi loa) nā pūnaewele beta a me ka hana ʻana i kahi microenvironment kākoʻo no ka hana hou ʻana o nā cell.
Mālama ʻia nā pae glucose koko paʻa, ma ke ala ʻole ma o ka ʻiʻo peripheral i hoʻomaikaʻi ʻia ʻike i ka insulin – ka ho'ēmiʻana i nāʻano likeʻole o ka insulin resistance a me ka hoʻonui hana mitochondrial.
Hoʻopau ʻo Pancragen i kēlā mau ala ola i ʻōlelo ʻia ma mua (PI3K/Act a MAPK/ERK).
Hoʻomaka ka hoʻomaka ʻana i nā ala apoptotic ma lalo o kahi hoʻouka ʻana i ka maʻi maʻi.
Ke noiʻi nei nā hoʻokolohua lapaʻau i ka hoʻōla hou ʻana o ke kelepona ma ke ʻano he hopena.
Hoʻoulu i ka mahele a me ka hoʻonui ʻana o kekahi mau cell, hui pū me ka microenvironment i ʻōlelo mua ʻia, hōʻike ia i kahi hoʻohuli kumu o ka piʻi ʻana o ka maʻi diabetes.
2.Hoʻoponopono Metabolic (e like me luna)
ʻIke ʻia ka hoʻomaikaʻi ʻana o ka insulin i nā ʻano holoholona.
Cytoprotection hoemi i ka hepatic a ʻiʻo adipose ʻaʻa mau.
Nā hopena pololei a me ka ʻole mea hoʻokipa insulin a ʻo ka hana transporter kekahi ʻāpana o ka hoʻomaikaʻi holoʻokoʻa i ka ʻike insulin.
Antioxidant a he waiwai noiʻi koʻikoʻi nā hopena anti-inflammatory o Pancragen.
Neuropathy a me metabolic syndrome ʻano pōʻino, a i ʻole kekahi maʻi e pili ana kaumaha oxidative, hiki a pono e pōmaikaʻi mai nā noi lapaʻau Pancragen.
COA
HPLC
MS





